SCHEMBL27139286

SCHEMBL27139286

Cc1n[nH]c(=O)n1Cc1ccc(Br)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ TDP1 Q9NUW8 4/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.41
▸ PARP1 P09874 1/20 0.39
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ ADRA1D P25100 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ ADRA1B P35368 1/20 0.35
▸ POLB P06746 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CYP2C9 P11712 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ PARP10 Q53GL7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21493503 0.71 KDM4E (0.44) KDM4ETDP1L3MBTL1ALDH1A1PARP1
SCHEMBL12692930 0.70 KDM4E (0.66) KDM4EL3MBTL1ALDH1A1MAPTHTT
Hydrochloric Acid SCHEMBL30693522 0.70 KDM4E (0.43) KDM4ETDP1L3MBTL1ALDH1A1PARP1
SCHEMBL27155113 0.70 KDM4E (0.43) KDM4ETDP1L3MBTL1ALDH1A1PARP1
SCHEMBL16422659 0.70 KDM4E (0.38) KDM4ETDP1L3MBTL1ALDH1A1MAPT
SCHEMBL30693452 0.67 ALDH1A1 (0.43) KDM4ETDP1L3MBTL1ALDH1A1PARP1
SCHEMBL12638603 0.66 HSP90AA1 (0.34) KDM4ETDP1L3MBTL1ALDH1A1KMT2A
SCHEMBL3520507 0.66 — —
SCHEMBL27148858 0.65 ALDH1A1 (0.44) KDM4ETDP1L3MBTL1ALDH1A1PARP1
SCHEMBL13134337 0.64 MAPT (0.44) KDM4ETDP1ALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12110279-B2 Triazolones, tetrazolones, and imidazolones, or their salts, and pharmaceutical compositions comprising the same YUHAN CORPORATION (KR) 2024-10-08 — — US disclosed
EP-4326715-A1 TRIAZOLONES, TETRAZOLONES, AND IMIDAZOLONES, OR THEIR SALTS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Yuhan Corporation (KR) 2024-02-28 — — EP disclosed
CN-117203205-A Triazolone, tetrazolone and imidazolone or salts thereof, and pharmaceutical compositions containing the same 柳韩洋行 2023-12-08 — — CN disclosed
US-20220380324-A1 TRIAZOLONES, TETRAZOLONES, AND IMIDAZOLONES, OR THEIR SALTS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME YUHAN CORPORATION (KR) 2022-12-01 — — US disclosed
WO-2022224195-A1 TRIAZOLONES, TETRAZOLONES, AND IMIDAZOLONES, OR THEIR SALTS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME YUHAN CORPORATION (KR) 2022-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12110279-B2 Triazolones, tetrazolones, and imidazolones, or their salts, and pharmaceutical compositions comprising the same VAPB, VAPA, FABP1 KDM4E 4371/4885TDP1 572/4885L3MBTL1 4112/4885
US-20220380324-A1 TRIAZOLONES, TETRAZOLONES, AND IMIDAZOLONES, OR THEIR SALTS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME VAPB, VAPA, FABP1 KDM4E 4371/4885TDP1 572/4885L3MBTL1 4112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback